Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors
Authors:
- 30 January 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (5) , 820-830
Abstract
A series of sulfonamide hydroxamic acids and anilides have been synthesized and studied as histone deacetylase (HDAC) inhibitors that can induce hyperacetylation of histones in human cancer cells. The inhibition of HDAC activity represents a novel approach for intervening in cell cycle regulation. The lead candidates were screened in a panel of human tumor and normal cell lines. They selectively inhibit proliferation, cause cell cycle blocks, and induce apoptosis in human cancer cells but not in normal cells. The structure−activity relationships, the antiproliferative activity, and the in vivo efficacy are described.Keywords
This publication has 18 references indexed in Scilit:
- Design and synthesis of a novel class of histone deacetylase inhibitorsBioorganic & Medicinal Chemistry Letters, 2001
- Potent and Selective Carboxylic Acid-Based Inhibitors of Matrix MetalloproteinasesJournal of Medicinal Chemistry, 2001
- Histone deacetylase inhibitor selectively induces p21 WAF1 expression and gene-associated histone acetylationProceedings of the National Academy of Sciences, 2000
- The language of covalent histone modificationsNature, 2000
- Histone deacetylase inhibitors: novel anticancer agentsExpert Opinion on Investigational Drugs, 1999
- Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide DerivativesJournal of Medicinal Chemistry, 1999
- Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylaseOncogene, 1999
- HDA1 and HDA3 Are Components of a Yeast Histone Deacetylase (HDA) ComplexJournal of Biological Chemistry, 1996
- (2E)-5-[3-[(Phenylsulfonyl)amino]phenyl]- pent-2-en-4-ynohydroxamic Acid and Its Derivatives as Novel and Potent Inhibitors of ras TransformationJournal of Medicinal Chemistry, 1996
- The total synthesis of (± )-trichostatin ATetrahedron, 1983